The present invention relates to compositions comprising a constituent, derivative or extract of cannabis in amorphous form. The invention also relates to products comprising such compositions and methods of manufacturing them.

A fixed dose combination formulation drug comprised of three cannabinoids, namely cannabidiol, cannabichromene, and cannabigerol, and of three terpenes, namely alpha-terpinene, bisabolol, and camphene, in an orally available pharmaceutical carrier, for the alleviation of the adverse effects of cancer chemotherapy agents, including adverse effects on the gastrointestinal tract, the chemoreceptor trigger zone, and the peripheral nervous system, and that shows activity adjunctively against ovarian cancer, particularly ovarian cancer that is therapeutically platinum-resistant or platinum-sensitive.

The present disclosure relates to natural ingredient compositions comprising hemp extracts and other optional active ingredients; and, to methods of their use for mind-body-balance including for improved energy, gut health, focus, relaxation, and sleep.

Proposed is an anti-obesity composition containing a hemp seed extract as an active ingredient. Specifically, food and pharmaceutical compositions for preventing or reducing obesity, each of which contains a hemp seed extract as an active ingredient, are proposed. Additionally, proposed is a method of preparing a hemp seed unsaponifiable extract having an anti-obesity activity. The method includes (1) adding a hemp seed, pyrogallol, and potassium hydroxide (KOH) to a reaction vessel and filling the reaction vessel with nitrogen, (2) causing a reaction in a water bath at a temperature in a range of 70 C. to 80 C. for 40 to 60 minutes and then cooling the resulting product, and (3) adding sodium chloride (NaCl) and an extraction solvent in which dibutylhydroxytoluene (BHT) hexane and ethyl acetate are mixed to the cooled product and shaking the resulting mixture to obtain a supernatant.

The present disclosure relates to a composition comprising an active ingredient or drug for degenerative disorders, one or more plant-derived neuroprotective ingredients and one or more nutraceutically or pharmaceutically acceptable excipient and a method of preparing the same. The composition delivers the active ingredient or the drug to the predetermined location of the body with success.

The task of loading oils into carrier particles can present significant technical challenges from an industrial perspective. The solution described herein includes mixing ingredients to produce the oil-loaded powder with a mixer imparting superimposed rotation and revolution movements to a container containing the ingredients, where the ingredients include a carrier in particulate form and an oil, and where the carrier is configured for (i.e., capable of) oil sorption. The oil-loaded powders have a substantially uniform distribution of the oil throughout the particles.

Various aspects of this patent document relate to liquid compositions comprising cannabidiol, which have either freezing points or glass-liquid transition temperatures less than the melting point of pure cannabidiol.

A method of processing hemp to obtain a desired hemp component includes providing a liquid solution including hemp into a press. The press is used to separate the liquid solution into a liquid faction and a solid faction, with the solid faction including hemp. A centrifuge is used to separate the liquid faction into heavy materials and a clarified liquid. The clarified liquid is the separated into waste and a desired component.

Provided are nutritional compositions having a non-soy-based plant protein component that includes chia proteins. Further disclosed are nutritional compositions having a non-soy-based plant protein source at a level of about 1 g/100 Kcal to about 9.5 g/100 Kcal, wherein at least about 30% of the protein source is a source of chia protein having a protein level of at least about 50% and a fiber level no greater than about 6%. The nutritional compositions disclosed are suitable for administration to human subjects, such as infants.

Particles, aqueous dispersions, and liquid compositions having high lipophilic component concentrations and high lipophilic component to surfactant ratios are described. The particles, aqueous dispersions, and liquid compositions can be used to efficiently deliver active compounds and/or active ingredients, such as cannabinoids including cannabidiol (CBD), through a variety of formulation types.